Smita Annie Maliekal

Smita Annie Maliekal is an experienced professional in the regulatory affairs sector, currently serving as the Director of Regulatory Affairs at Immunovant since December 2020, following a role as Associate Director of Regulatory Affairs Operations. Prior experience includes positions as a RIM Business Analyst at Orion Innovation for Bristol-Myers Squibb, and Sr. Manager of RIM Business Process at Amicus Therapeutics. Smita has held significant roles at Daiichi Sankyo, Bristol-Myers Squibb, and various other companies, focusing on regulatory affairs, document management systems, and technical analysis. Smita holds a Master of Science in Computer Engineering from Wright State University and a Bachelor of Engineering from Poona University.